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Overexpression of Transforming Growth Factor b1 in Smooth Muscle
Cells of Human Abdominal Aortic Aneurysm
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First Department of Surgery, Shinshu University School of Medicine, 3-1-1 Asahi,
Matsumoto 390-8621, Japan
Objective: to examine the expression of transforming growth factor b1 (TGF-b1) and the cell kinetics of smooth muscle
cells (SMCs) at the neck of abdominal aortic aneurysms (AAAs).
Materials and Methods: expression of a-smooth muscle actin and TGF-b1 was evaluated by immunostaining, and cell
kinetics were estimated by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) assay
and Ki-67 immunostaining in 11 AAAs (at both the dilated region and the neck) and eight occlusive aortas.
Results: the TUNEL-positive SMC ratio in the neck and dilated region was significantly higher than in the occlusive aorta
(p5 0.01). The percentage of Ki-67-positive SMCs in the neck was significantly higher than in the dilated region
(p5 0.01) and the occlusive aorta (p 0.032). When compared with the occlusive aorta, the aneurysmal neck had increased
TGF-b1 expression (p 0.01) and reduced SMC density, and the aneurysmal dilated aorta had much more increased
TGF-b1 expression (p5 0.01) and much more reduced SMC density (p5 0.01).
Conclusions: these results suggest that overexpression of TGF-b1 might be associated with the reduction of SMC density
through SMC apoptosis and reduced proliferative ability of SMCs, leading to dilatation in AAAs.
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Introduction
Infrarenal abdominal aortic aneurysms (AAAs) are
characterised by intimal atherosclerosis, which is
similar to arteriosclerosis obliterans (ASO), and
degeneration of the medial layer associated with a
pronounced decrease in aortic elastin fibers,1,2 which
is different from ASO. Vascular smooth muscle cells
(SMCs) are the physiologically dominant cells in the
medial layer. According to some recent reports, apop-
tosis of SMCs has been observed in the degenerate
media AAAs.3±5
However, as SMCs are capable of regeneration and
proliferation in injured vessels,6 SMCs may be regen-
erated to proliferate with AAA aneurysm. Transform-
ing growth factor b1 (TGF-b1) is a pleiotropic factor
expressed within vascular cells, and regulates cell
growth in a tissue-specific manner. TGF-b1 has been
reported to arrest growth in the G1 phase of the cell
cycle,7 and to play an important role as an inducer of
apoptosis in a variety of cells.8±10 Although it has been
reported that TGF-b1 inhibits the proliferation of
vascular SMCs,11 no study has yet demonstrated the
expression of TGF-b1 in SMCs of AAAs.
In this study, we examined the expression of TGF-b1
and the cell kinetics of SMCs both at the region of
aneurysmal neck and aneurysmal dilation to assess




Approval from the Medical Ethics Committee of
Shinshu University School of Medicine was obtained
for collection of samples. Informed consent was
obtained from the patients. Because the medial layer
of the occlusive aorta has histologically normal SMCs3
and both aneurysmal aorta and occlusive aorta have
similar intimal changes, we compared the medial
layer of AAA with that of occlusive aortas. An antero-
lateral section of aorta (ASO cases), the AAA neck
and dilated region, were collected during surgery
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from eight occlusive and 11 aneurysmal human
aortas. In this study, aneurysmal neck refers to the
border area where aneurysmal enlargement begins.
Ruptured, thoracoabdominal and inflammatory
aneurysms were excluded from the study. The aver-
age diameter of the AAAs was 5.1 (range, 4.1±6.0 cm).
The average age was 74 (range, 55±83) years for
patients with AAAs, and 67.5 (range, 50±81) years
for patients with ASO (Table 1). Specimens were
fixed immediately in 8% paraformaldehyde at 4 C
for 20±22 h, and then embedded in paraffin.
a-Smooth muscle actin and TGF-b1 immunostaining
Specimens were cut into 4-mm serial sections onto
glass slides coated with poly-l-lysine. Four serial sec-
tions were prepared, and a-actin immunostaining was
performed using the second or third section. Depar-
affinized rehydrated tissues were incubated in metha-
nol containing 0.3% hydrogen peroxidase for 30 min to
block the endogenous peroxidase activity. The sec-
tions were washed in 0.01 mol/L Tris-HCl (pH 7.5)/
150 mmol/L NaCl (TBS), and blocked with 1% bovine
serum albumin (BSA) (Sigma, St Louis, MO, U.S.A.).
For a-smooth muscle immunostaining, the sections
were incubated at room temperature for 1 h with alka-
line phosphatase-conjugated anti-a-smooth muscle
actin (Sigma) in 1% BSA, and the reaction product
was developed using New Fuchsin substrate
(DAKO). For TGF-b1 immunostaining, the sections
were incubated at room temperature for 1 h with
anti-TGF-b1 antibody (Santa Cruz, CA, U.S.A.) at a
dilution of 1:500 in 1% BSA, and antibody binding
was visualized using the streptavidin-biotin system
(DAKO, Glostrup, Denmark) and 3,3-diaminobenzi-
dine. Staining development was stopped by immer-
sion in tap water, and nuclei were counterstained with
hematoxylin. In negative controls, all reagents except
the primary antibody were used.
Terminal deoxynucleotidyl transferase-mediated
dUTP-biotin nick end-labeling (TUNEL) assay
To detect cells undergoing apoptosis, the tissue sec-
tions were stained using the TUNEL procedure with
some modifications. The tissue sectioned at 4 mm was
dewaxed, rehydrated, and digested with 20 mg/mL
proteinase K (Sigma). Endogenous peroxidase was
blocked by treatment with 0.3% hydrogen peroxidase.
Sections were then rinsed in water and incubated with
50 mL of terminal deoxynucleotidyl transferase (TdT)
buffer (30 mmol/L Tris-HCl [pH 7.2], 140 mmol/L
sodium cacodylate, 1 mmol/L cobalt chloride) con-
taining 8.3 U TdT (Boehringer Mannheim, Mannheim,
Germany) and 0.83 nmol biotinylated 16-deoxyuridine
triphosphate (Boehringer±Mannheim) in a moist
chamber at 37 C for 60 min. Then, the sections were
rinsed and incubated with HRP-conjugated streptavi-
din (DAKO) diluted 1:500 in TBS containing 1% BSA
for 30 min at room temperature, then rinsed in TBS
and stained with diaminobenzidine.
Ki-67 immunostaining
Proliferative activity of aortic SMCs was detected by
immunostaining for Ki-67 protein in the nuclei of cells.
After the 4-mm sections had been dewaxed, antigen
retrieval was performed using a microwave oven.
Endogenous peroxidase blocking was then performed.
Sections were incubated with 100 mg/mL anti-human
mouse monoclonal Ki-67 antibody (DAKO) at a dilu-
tion of 1:50 for 90 min at 37 C. Antibody binding was
visualized using the labeled streptavidin biotin (LSAB)
method (DAKO LSAB Kit), and 3,3-diaminobenzidine.
Then, cell nuclei were counterstained with hema-
toxylin and mounted.
Morphological analysis
Color images of the immunohistochemically stained
sections at 400 magnification were saved in a
Macintosh personal computer (Apple Computers,
Cupertino, CA, U.S.A.) using a Fujix digital camera
HC 2500 (Fuji Photo Film Co., Ltd, Tokyo, Japan) and
computer-assisted image analysis software, NIH
Image version 1.60 (National Institutes of Health,
Bethesda, MD, U.S.A.). The captured images were
projected on the computer monitor. The immunohisto-
chemical staining was analyzed by two independent
observers in a blind manner.
First, a randomly chosen color image on the a-
actin-immunostained section was viewed on the
Table 1. SMC density and apoptosis for each aortic tissues.






Occlusive aorta 8 67.5 (50±81) 163 (130±181) 1.2 (0±2.9)
Aneurysmal neck 11 74 (55±83) 124 (85±151)  3.6 (0±6.8) 
Aneurysmal
dilated aorta
11 74 (55±83) 90 (42±144) y 0.5 (0±6.1)
SMC: smooth muscle cell.
Values are expressed as median (range). p5 0.05.
{ p5 0.01 compared with occlusive aorta.
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monitor, and the number of a-actin-positive cells were
counted and recorded. The same field in the TGF-b1-
immunostained (or TUNEL assay or Ki-67 immuno-
stained) section was then identified and displayed next
to the a-actin immunostaining image on the monitor.
Then, TGF-b1-positive cells (or apoptotic cells or Ki-
67-positive cells) were identified by one-to-one corres-
pondence with a-actin-positive cells on the monitor,
and the positive cells were counted. These procedures
were repeated in four randomly chosen areas.
Statistical analysis
The differences were evaluated with the Mann±
Whitney U test for comparison between occlusive
aortas and aneurysmal necks or between occlusive
aortas and aneurysmal dilated regions, and with
the Wilcoxon signed rank sum test for comparison
between aneurysmal necks and aneurysmal dilated
regions. All analyses were performed with the
Statview 5.0 statistical software package (Abacus
Concepts, Berkley, CA, U.S.A.). The results are
presented as median (range) and are considered
significant at p5 0.05.
Results
The a-actin antibody-positive SMCs predominated in
the medial layer of the occlusive aorta and the aneur-
ysmal neck, but SMCs in the aneurysmal dilated
region showed a disrupted and disorganized pattern
(Fig. 1A). The aneurysmal dilated had significantly
fewer SMCs in the medial layer compared with the
occlusive aorta (p5 0.01) and the aneurysmal neck
Fig. 1. (A) a-Actin antibody immunostaining of the occlusive aorta. (B) TUNEL assay of the aneurysmal dilated region. (C) Ki-67
immunostaining of the aneurysmal neck. (D) TGF-b1 immunostaining of the aneurysmal dilated region. Original magnification 400.
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(p5 0.01) (Table 1). There was a significant difference
in SMC density between the aneurysmal neck and the
occlusive aorta (p5 0.01).
The ratio of TUNEL-positive SMCs in the aneurys-
mal neck (29%, range 8±34%) was significantly
increased compared with that in the occlusive aorta
(12%, range 4±17%, p5 0.01). The ratio of TUNEL-
positive SMCs in the aneurysmal dilated region
(40%, range 4±59%) varied widely among patients
but significantly increased compared with that in the
occlusive aorta (p5 0.01) and aneurysmal neck
(p 0.015) (Figs 1B and 2).
Proliferating SMCs were observed in the medial
layer of AAAs with Ki-67 immunostaining. The per-
centage of Ki-67-positive SMCs in the aneurysmal
neck (3.6%, range 0±6.8) was significantly higher
than in the aneurysmal dilated region (0.5%, range
0±6.1, p5 0.01) and the occlusive aorta (1.2%, range
0±2.9, p 0.032) (Table 1, Fig. 1C).
TGF-b1-positive SMCs were visualized in the aortic
media. The ratio of TGF-b1-positive SMCs in the aneur-
ysmal dilated region (42%, range 29±60%) was much
higher than that in the aneurysmal neck (13%, range
10±27%, p5 0.01) and that in the occlusive aorta (7%,
range 5±17% p5 0.01) (Fig. 1D). The ratio of TGF-b1-
positive SMCs in the aneurysmal neck was significantly
higher than that in the occlusive aorta (p 0.01) (Fig. 3).
Figure 4 shows the relationship between TGF-b1
expression and SMC density in the occlusive aorta,
the aneurysmal neck, and the aneurysmal dilated
region. Compared with the occlusive aorta, the neck
had increased TGF-b1 expression and reduced SMC
density, and the aneurysmal dilated aorta had much
more increased TGF-b1 expression and much more
reduced SMC density.
Discussion
Many studies has shown AAA, to be associated with
diminished elastin content,1,12,13 predominance of des-
tructive proteases such as MMP-2 and MMP-9,14±16
and apoptosis of SMCs.3±5 However, a histological
approach using the aneurysmal dilated region alone,
Fig. 2. The percentage of TUNEL-positive nuclei in the occlusive
aorta, the aneurysmal neck, and the aneurysmal dilated region. p5 0.05,  p5 0.01, NS: not significant. ASO: arteriosclerosis
obliterans, AAA: abdominal aortic aneurysm.
Fig. 3. The percentage of TGF-b1-positive cells in the occlusive
aorta, the aneurysmal neck, and the aneurysmal dilated region. p5 0.05,  p5 0.01. ASO: arteriosclerosis obliterans, AAA:
abdominal aortic aneurysm, TGF: transforming growth factor,
SMC: smooth muscle cell.
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which is severely damaged and the final state of the
condition, can provide little information about the
etiology of AAAs. Therefore, in this study, we inves-
tigated the aneurysmal neck as the border area for
aneurysmal enlargement.
Lopez-Candales et al. documented a decrease of
SMC density and an increased number of apoptotic
SMCs in the media AAAs.3
Thompson et al. also found an increased number of
apoptotic SMCs in aneurysmal aortic tissue when
compared with normal human aorta.4 However,
these studies did not refer to the regional differences
of SMC density or SMC apoptosis in AAAs. It is
postulated that vascular lesion formation and
remodeling involves a balance between vascular cell
death and cell proliferation. There has been no report
on imbalance between SMC apoptosis and proli-
feration in AAAs. Studies of possible imbalance are
important for research on the etiology of AAAs, as
shown by Isner et al., who reported that apoptosis
may, by proliferation of SMCs, modulate the cellularity
of lesions that produce human coronary vascular
obstruction.17 Therefore, we compared aneurysmal
necks with occlusive aortas in terms of the balance
between SMC death and proliferation. We found that
the increased SMC apoptosis was accompanied by a
decrease in SMC density in the aneurysmal neck, and
Ki-67 immunostaining showed accentuation of SMC
proliferation only in the aneurysmal neck of the
AAAs. These findings indicate that, while SMC prolif-
eration occurs at the aneurysmal neck, it does not
compensate for SMC apoptosis, and thus SMC density
is reduced in the aneurysmal neck. This suggests
that aneurysmal dilatation could begin in the
aneurysmal neck.
Recently, many reports have referred to the modu-
lation by TGF-b1 in vascular smooth muscle cell apop-
tosis.8,11,18±20 However, no reports have documented
the expression of TGF-b1 in SMCs of AAAs. In the
present study we focused the expression of TGF-b1,
which is reported to have important role to inhibit the
proliferation of vascular SMCs,11 both in the aneurys-
mal neck and in the aneurysmal dilated region to
assess the relationship between TGF-b1 expression
and aneurysm formation. And it was revealed that
the aneurysmal neck had increased TGF-b1 expression
and reduced SMC density, and the aneurysmal dilated
region had much more increased TGF-b1 expression
and much more reduced SMC density, when com-
pared with the occlusive aorta. Together with the gen-
erally accepted apoptotic function of TGF-b1, it is
suggested that overexpression of TGF-b1 might be
associated with the reduction of SMC density through
SMC apoptosis and reduced proliferative ability of
SMCs, leading to aneurysmal dilatation in AAAs.
Moreover we suppose that increased TGF-b1 expres-
sion in SMCs might associated with the trigger of
aneurysmal dilatation in the early period of vascular
remodelling because TGF-b1 expression in SMCs has
already increased in the aneurysmal neck.
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